Capitalisation Boursière Changement Date
Adma Biologics USD 4.34B 845M 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Xencor USD 1.09B 256M 2025-12